Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Sarcoma
What dose-fractionation and clinical target volume do you use when treating tenosynovial giant cell tumor (TGCT), historically known as pigmented villonodular synovitis (PVNS), of the knee?
Answer from: Radiation Oncologist at Community Practice
4500 cGy at 180cGy/fx.
Sign in or Register to read more
14297
Related Questions
Is it appropriate to use electrons to treat a fibrosarcomatous DFSP of the face s/p R1 WLE?
What is the recommended approach for a 7 cm x 5 cm paraspinal subcutaneous desmoid tumor (T6 to T9) incidentally detected on PET CT during NSCLC monitoring, with confirmed growth over 18 months?
How would you manage an epidural spinal metastasis causing cord compression from rhabdomyosarcoma?
Would you offer adjuvant radiation for a DFSP with fibrosarcomatous transformation s/p wide local excision?
How do you approach a patient with undifferentiated pleomorphic sarcoma encasing the spinal cord post radiation for neurological deficits for further management?
What dose/fractionation would you recommend for primary aneurysmal bone cyst of spine after a subtotal resection?
How will you treat an uterine embryonal rhabdomyosarcoma with regional node involvement resected to involved parametrial margins?
How would you approach adjuvant treatment in a patient with completely resected undifferentiated pleomorphic sarcoma of the chest wall that recurred after 2 years, initially treated with neoadjuvant radiation and resection?
Would you use neoadjuvant TKI or neoadjuvant radiation for a large chest wall sarcoma with an NTRK fusion on NGS?
Would you recommend post operative radiation in an adult patient with a thoracic spine osteosarcoma?